Intensive Multidisciplinary Intervention for Young Children With ARFID: Clinical Outcomes and Parental Experiences...

Area of Science:

• Pediatric Gastroenterology
• Child Psychology
• Clinical Nutrition

Background:

• Avoidant Restrictive Food Intake Disorder (ARFID) presents significant challenges in pediatric populations.
• Early intervention is crucial for managing severe eating difficulties in children.
• Understanding parental experiences is key to optimizing treatment delivery for ARFID.

Purpose of the Study:

• To evaluate the clinical outcomes of an intensive multidisciplinary intervention (IMI) for children diagnosed with ARFID.
• To assess parental satisfaction and experiences with the IMI program.
• To identify specific ARFID profiles that may benefit most from intensive intervention.

Main Methods:

• A prospective cohort study involving 28 children (aged 2-8 years) with severe eating difficulties meeting ARFID criteria.
• An 8-day IMI incorporating guided mealtimes, play-based exposures, nutritional counseling, and caregiver coaching.
• Clinical outcomes assessed via PARDI at baseline and 7-15 months post-intervention; parental experience evaluated using ESQ and EIEQ.

Main Results:

• While 27/28 children still met ARFID criteria at follow-up, overall symptom severity significantly decreased (p < 0.001).
• Significant reductions were observed in both sensory-based (p = 0.002) and low-interest ARFID profiles (p < 0.001).
• Improvements in nutritional status and growth criteria were noted, alongside high parental satisfaction with the intervention's multidisciplinary approach and practical strategies.

Conclusions:

• Intensive, multidisciplinary, nondirective interventions show promise for reducing ARFID symptoms in young children, especially those with sensory and low-interest profiles.
• The intervention enhanced caregiver competence and supported symptom reduction, though full remission was infrequent within the follow-up period.
• Further controlled studies are necessary to confirm efficacy and develop sustainable care models for pediatric ARFID.